发明名称 TETRACYCLINE-REGULATED GENE EXPRESSION IN HSV-1 VECTORS
摘要 The present invention is directed to HSV-1 vectors which rely on the tetracycline repressor and operator as a means for regulating expression. The vectors utilize VP-16 responsive promoters of HSV to control expression of the tetracycline repressor. The vectors are of particular interest as vehicles for recombinantly expressing genes in vivo.
申请公布号 US2015337319(A1) 申请公布日期 2015.11.26
申请号 US201514823669 申请日期 2015.08.11
申请人 THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 发明人 YAO Feng
分类号 C12N15/63;C12N7/00;C07K14/005;C12N15/86 主分类号 C12N15/63
代理机构 代理人
主权项 1. An HSV-1 viral vector having a genomic DNA construct comprising: a) at least two tetR nucleotide sequences coding for the tetracycline repressor, wherein the expression of each tetR nucleotide sequence is under the control of a VP-16 responsive immediate early promoter selected from the group consisting of: the ICP-0 immediate early promoter of HSV-1; the ICP-4 immediate early promoter of HSV-1; LAP2/ICP0; and LAP2/ICP4; b) an additional promoter wherein additional promoter includes a TATA element; c) a tetracycline operator sequence positioned between 6 and 24 nucleotides 3′ to said TATA element; and d) a structural sequence whose expression is regulated by said additional promoter.
地址 Boston MA US